{
  "id": 20767780,
  "title": "Novartis details eczema win, autoimmune CAR-T efforts after rocky quarter",
  "url": "https://urgent.news/2026/11/19/novartis-details-eczema-win-autoimmune-car-t-efforts-after-rocky",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-19T15:34:02.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/novartis-details-eczema-win-autoimmune-car-t-efforts-after-rocky-quarter/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Novartis touted a mid-stage win for its eczema drug, revealed it is working toward restarting trials of its autoimmune CAR-T cell therapy and slightly trimmed the top of its sales-growth guidance through 2031. CEO Vas ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}